UHenry Ji
USihlalo, uMongameli kunye ne-CEO
- Iminyaka engama-25+ yamava kwi-biotechnology kunye neshishini lesayensi yobomi
- UDkt Ji waseka i-Sorrento kwaye uye wakhonza njengomlawuli ukususela ngo-2006, i-CEO kunye noMongameli ukususela ngo-2012, kunye noSihlalo ukususela ngo-2017.
- Ngethuba lokuhlala kwakhe e-Sorrento, uye wenza ubunjineli kwaye wakhokela ukukhula okumangalisayo kwe-Sorrento ngokufunyanwa kunye nokudibanisa kuquka i-Bioserv, i-Scilex Pharmaceuticals, i-Concortis Biotherapeutics, i-Levena Biopharma, i-LACEL, i-TNK Therapeutics, i-Virttu Biologics, i-Ark Animal Health, kunye ne-Sofurysa Systems Lymphatic System.
- Usebenze njengeGosa eliyiNtloko lezeNzululwazi le-Sorrento ukusuka ngo-2008 ukuya ku-2012 nanjenge-CEO yayo yeThutyana ukusuka ngo-2011 ukuya ku-2012.
- Ngaphambi kwe-Sorrento, wayenezikhundla eziphezulu eziphezulu kwi-CombiMatrix, i-Stratagene kwaye waseka i-Stratagene Genomics, i-subsidiary ye-Stratagene, kwaye wasebenza njengoMongameli kunye ne-CEO kunye noMlawuli weBhodi.
- BS kunye nePh.D.
Vala u-X
Dorman Ukulandela
umlawuli
- UMnu. Followwill, usebenze njengomlawuli ukususela ngoSeptemba 2017
- Ube nguMlingani oMkhulu, iMpilo yoTshintsho kwiFrost & Sullivan, iqumrhu lokubonisana neshishini elibandakanyekayo kuphando lwemarike kunye nohlalutyo, ukubonisana kwesicwangciso sokukhula kunye noqeqesho lwenkampani kuwo wonke amashishini amaninzi, ukususela ngo-2016.
- Ngaphambi kwelo xesha, wasebenza kwiindima ezahlukeneyo kwi-Frost & Sullivan, kubandakanywa noMlingane kwiKomiti eLawulayo elawula i-P & L yoshishino eYurophu, kwaSirayeli kunye ne-Afrika, kunye ne-Partner ejongene ne-Healthcare kunye ne-Life Sciences ishishini eNyakatho Melika, ukususela ekuqaleni ukujoyina. UFrost noSullivan bancedisa ekufumaneni uQeqesho lokuNxibelelana ngoJanyuwari ka-1988
- UMnu. Followwill uneminyaka engaphezulu kwama-30 yobunkokeli bombutho kunye namava okucebisana nolawulo, esebenze kumakhulu eeprojekthi zokubonisana kuyo yonke imimandla emikhulu nakumacandelo oshishino amaninzi, iprojekthi nganye igxile kummiselo weqhinga lokukhula.
- BA
Vala u-X
UKim D. Janda
umlawuli
- UGqr. Janda usebenze njengomlawuli ukusukela ngoAprili ka-2012
- UDkt. Janda ube ngu-Ely R. Callaway, u-Jr. uSihlalo onguNjingalwazi kwiSebe leKhemistry, i-Immunology kunye neSayensi yeMicrobial kwi-Scripps Research Institute ("TSRI") ukususela ngo-1996 kwaye njengoMlawuli we-Worm Institute of Research and Medicine ( “WIRM”) e-TSRI ukusukela ngo-2005. Ngaphezu koko, uGqr. Janda usebenze njengoMfundi we-Skaggs ngaphakathi kwe-Skaggs Institute of Chemical Biology, nakwi-TSRI, ukususela ngo-1996.
- Upapashe ngaphezu kwe-425 iimpapasho zokuqala kwiijenali eziphononongelwe ngoontanga kwaye waseka iinkampani ze-biotechnological CombiChem, i-Drug Abuse Sciences kunye ne-AIPartia uGqr. Janda ngumhleli odibeneyo we "Bioorganic & Medicinal Chemistry", "PLoS ONE" kwaye ukhonza, okanye uye wakhonza. , kwiibhodi zabahleli beejenali ezininzi kuquka noJ. Comb. Ikhemi, iChem. Uphononongo, J. Med. Chem., Ijenali yeBotulinum, iBioorg. kunye noMed. Ikhem. Lett., kunye neBioorg. kunye noMed. Ikhem
- Ngaphezulu kwekhondo lomsebenzi elingaphezu kweminyaka engama-25, uGqr. Janda unikezele ngeminikelo emininzi kwaye uthathwa njengenye yezazinzulu zokuqala ukudibanisa iindlela zekhemikhali kunye nebhayoloji zibe yinkqubo yophando edibeneyo.
- UGqr. Janda uye wakhonza kwiBhodi yeeNgcebiso zeNzululwazi yeMateria kunye neSebe lezeMfundo laseSingapore
- BS kunye nePh.D.
Vala u-X
UDavid Lemus
umlawuli
- UMnu. Lemus usebenze njengomlawuli weNkampani ukusukela ngoSeptemba ka-2017
- Ngoku uyi-CEO ye-Ironshore Pharmaceuticals, Inc.
- Ukongeza, usebenza njengelungu elingelolungu lebhodi yeSilence Therapeutics (NASDAQ: SLN) kunye neBioHealth Innovation, Inc.
- Ngaphambili eSigma Tau Pharmaceuticals, Inc. ukusuka kwi-2011-2015, usebenze njenge-CEO.
- Ukongeza, uMnu. Lemus usebenze njenge-CFO kunye ne-VP ye-MorphoSys AG ukusuka ngo-1998-2011, ethatha inkampani yoluntu kwi-IPO yokuqala yebhayoloji yaseJamani.
- Phambi kwendima yakhe eMorphoSys AG, ebebambe izikhundla ezahlukeneyo zolawulo eziquka iinkampani iHoffman La Roche, Electrolux AB, kunye neLindt & Spruengli AG (iQela likaNondyebo).
- BS, MS, MBA, CPA
Vala u-X
Jaisim Shah
umlawuli
- UMnu. Shah usebenze njengomlawuli ukususela ngo-2013
- Iminyaka eyi-25+ yamava kwishishini lamayeza
- UMnu. Shah ngoku usebenza njenge-CEO kunye noMongameli we-Scilex Holding kunye ne-Scilex Pharmaceutical
- Ngaphambi kweScilex, usebenze njenge-CEO kunye noMongameli we-Semnur Pharmaceuticals (efunyenwe yi-Scilex Pharmaceuticals) oko yasungulwa ngo-2013.
- Ukusukela ngo-2011 ukuya ku-2012, usebenze njengeGosa eliyiNtloko loShishino kwi-Elevation Pharmaceuticals apho wayegxile kwinkxaso-mali, ukudibanisa kunye nokufumana, kunye nophuhliso lweshishini.
- Ngaphambi kokuPhakanyiswa, uMnumzana Shah wayenguMongameli weZelos Therapeutics, apho wayegxile kwinkxaso-mali kunye nophuhliso lweshishini.
- Ngaphambi kweZelos, uMnumzana Shah wayeyiSekela likaMongameli oPhezulu kunye neGosa eliPhezulu leShishini kwiCytRx. Ngaphambili, uMnumzana Shah wayeliGosa eliyiNtloko leShishini kwiFacet Biotech kunye nePDL BioPharma apho waye wagqibezela iilayisenisi ezininzi/intsebenziswano kunye neqhinga lentengiselwano.
- Ngaphambi kwe-PDL, uMnumzana Shah wayeyi-VP yeNtengiso yeHlabathi kwi-BMS apho wafumana i-"Presidents Award" ngokugqibezela eyona ntsebenziswano ibalulekileyo kwimbali yenkampani.
- MA kunye neMBA
Vala u-X
Nguye Alexander Wu
umlawuli
- UGqr. Wu usebenze njengomlawuli ukususela ngo-Agasti ka-2016
- Ngoku ukwasebenza kwiBOD yeScilex Pharmaceutical ukusukela ngo-2019
- UGqr. Wu wayengumseki, i-CEO, uMongameli, kunye neGosa eliyiNtloko lezeNzululwazi ye-Crown Bioscience International, inkampani ehamba phambili yokufunyanwa kweziyobisi kunye nezisombululo zophuhliso, awayisungula ngo-2006.
- Ukususela kwi-2004 ukuya kwi-2006, wayeyiNtloko yezoShishino lwe-Starvax International Inc. e-Beijing, e-China, inkampani ye-biotechnology egxile kwi-oncology kunye nezifo ezithathelwanayo.
- Ukusuka ngo-2001 ukuya ku-2004, wayengumgcini-bhanki kunye ne-Burrill & Company apho wayeyintloko ye-Asian Activities.
- BS, MS, MBA, kunye nePh.D.
Vala u-X